Pelvic floor electrical stimulation devices are a fairly new long-term therapeutic solution for the strengthening of weakened pelvic floor muscles, which could potentially be used to minimize the effects of neurodegenerative disease, sexual dysfunction, and urinary incontinence among women and geriatrics. Rising investments in the healthcare sector towards research & development on intra-anal or intra-vaginal pelvic electric-powered stimulators are likely to boost demand for these devices in the long term, driven by key players such as Atlantic Therapeutics, TensCare Ltd., and Verity Medical Ltd.
The global pelvic floor electrical stimulation devices market is expected rise strongly and hit a US$ 800 million valuation by the end of the forecast period (2020 to 2030). On the other hand, the industry is likely to be moderately affected by the COVID-19 pandemic, owing to temporary restrictions imposed on elective healthcare.
To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=5245
Key Takeaways from Pelvic Floor Electrical Stimulation Devices Market Study
- Mobile pelvic floor electrical stimulation devices will account for a significant market share as compared to fixed alternatives. Cost benefits, high level of portability, and application in home care settings contribute to the segment’s domination.
- Urinary Incontinence applications will contribute major revenue share through the forecast period. Demand, particularly from geriatrics and pregnant women, will provide strong impetus.
- Hospitals are likely to remain the leading end user in the pelvic floor electrical stimulation devices market throughout the duration of the forecast period, supported by higher patient footfall, and easy access to capital and new technologies.
- North America is estimated to remain the leading regional pelvic floor electrical stimulation devices market through the projection period, aided by major investments in research on neurodegenerative disease and sexual dysfunction issues.
- Improvements in terms of telemedicine technology, particularly following the outbreak of the COVID-19 virus, are supporting the rise of the pelvic floor electrical stimulation devices market.
“With the COVID-19 pandemic affecting the whole world, and putting stress on the healthcare sector, non-essential medical procedures have been postponed, which is projected to impede market growth in the near term,”says a Fact.MR analyst.
Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=5245
Pelvic Floor Electrical Stimulation Devices Market: Segmentation
Fact.MR has studied the pelvic floor electrical stimulation devices market with in-depth segmentation on the basis of product type, application, end user, and region.
Product Type
Application
- Urinary Incontinence Treatment
- Neurodegenerative Diseases
- Sexual Dysfunction
- Others
End User
- Hospitals
- Clinics
- Home Care Settings
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than the addressee(s) is unauthorized and prohibited.”
Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/5245
Pelvic Floor Electrical Stimulation Devices Market: Key Players
Major companies in the pelvic floor electrical stimulation devices market are expected to hold on to substantial market share on the back of capital and investments into potential new technology. On the whole, market players are likely to focus efforts and resources towards research & development to keep up with patient needs, and applications in more severe cases, in compliance with the standards of regulatory bodies.
- For instance, Pelvital introduced its new Flyte pelvic floor electrical stimulation device, which has received approval from the FDA for treating conditions of stress urinary incontinence. It is a non-invasive, intravaginal device aimed for home care applications.
- Similarly, InControl Medical announced FDA approval for its new pelvic floor electrical stimulation device – Attain, which is to be distributed as a non-implantable OTC offering for use in home care settings.
Fact.MR has analyzed prominent companies in the pelvic floor electrical stimulation devices market, to study the competitive scenario of the sector, including Utah Medical Products Inc., Atlantic Therapeutics, Shenzhen XFT Medical Ltd., The Prometheus Group, Zynex Medical, KayCo2 Ltd., Laborie Inc., TensCare Ltd., and Verity Medical Ltd., among others.
For More Insight- https://www.factmr.com/article/124/latest-trends-in-the-healthcare-industry-how-has-it-transformed-businesses
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
